CCL2 and neoplasm: Besides promoting tumor progression by acting on both tumor and non-tumor cells from the tumor microenvironment, these proteins strongly chemoattract monocytes (MCP-1) and neutrophils and T cells (IL-8) to both primary and metastatic tumors [82].